HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma.

AbstractBACKGROUND AND PURPOSE:
To investigate influences of proteins involved with tumor immunity on outcomes of radiotherapy for oropharyngeal squamous cell carcinoma (OPSCC).
MATERIAL AND METHODS:
We performed immunohistochemical staining to examine expressions of p16 and proteins involved with tumor immunity in 92 OPSCC patients treated with radiotherapy.
RESULTS:
Patients with abundant infiltrating CD8-positive cells had the significantly better overall survival (OS) rate than patients with fewer CD8-positive cells (p = 0.026). Patients with higher PD-L1 expression in tumor cells (TC 1-3) had a better outcome than those with low PD-L1 expression in tumor cells (TC 0) for both OS (p = 0.019) and progression-free survival (PFS) rate (p = 0.032). Patients with high PD-L1 expression in infiltrating immune cells (IC 3) showed significantly better OS (p = 0.009) and PFS (p = 0.011) than those with low PD-L1 expression (IC 0-2). Patients with p16-negative and IC 3 showed similar OS to patients with p16-positive and IC 0-2. P16-positive tumors had a significantly higher CD8-positive cell infiltration and PD-L1 expression in tumor cells than p16-negative tumors.
CONCLUSIONS:
In addition to tumor p16 expression, PD-L1 expression in TC and IC can be useful for predicting the response of OPSCC to radiotherapy.
AuthorsYuki Fukushima, Masanori Someya, Kensei Nakata, Masakazu Hori, Mio Kitagawa, Tomokazu Hasegawa, Takaaki Tsuchiya, Toshio Gocho, Hikaru Ikeda, Yoshihiko Hirohashi, Toshihiko Torigoe, Shintaro Sugita, Tadashi Hasegawa, Tetsuo Himi, Koh-Ichi Sakata
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 129 Issue 2 Pg. 409-414 (11 2018) ISSN: 1879-0887 [Electronic] Ireland
PMID30249348 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018. Published by Elsevier B.V.
Chemical References
  • B7-H1 Antigen
  • Biomarkers, Tumor
  • CD274 protein, human
  • Neoplasm Proteins
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • B7-H1 Antigen (metabolism)
  • Biomarkers, Tumor (metabolism)
  • CD8-Positive T-Lymphocytes (immunology)
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Male
  • Middle Aged
  • Neoplasm Proteins (metabolism)
  • Oropharyngeal Neoplasms (immunology, pathology, radiotherapy)
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck (immunology, pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: